Gender-sensitive frailty prediction using clinical, biological, and psycho-social data
Official title: Integration of Clinical, Biological and Psycho-social Variables for a Gender-sensitive Frailty Prediction (Age-It: Ageing Well in an Aging Society - A Novel Public-private Alliance to Generate Socioeconomic, Biomedical and Technological Solutions for an Inclusive Italian Ageing Society)
Run by University of Roma La Sapienza · NCT07109596 · Data updated 2026-11-12
This project will test whether combining clinical, biological, and gender-related social information can predict frailty in adults over 55 admitted to internal medicine or geriatric wards.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 56 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | University of Roma La Sapienza Academic / other |
| Locations | 1 site (Roma) |
| Status | Recruiting |
| Started | June 1, 2025 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2028 |
| Registry record updated | August 7, 2025 |
| Trial ID | NCT07109596 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults older than 55 who are admitted to internal medicine or geriatric wards and do not have active cancer or need ICU-level care.
✕Probably not a fit
People undergoing surgery, those currently in intensive care, or patients with active malignancy would be excluded and are unlikely to benefit from this project.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational project will collect clinical, laboratory (including thrombo-inflammatory and nutritional markers), and psycho-social variables from patients aged over 55 admitted to internal medicine or geriatric units at Policlinico Umberto I in Rome. Investigators will create a gender-oriented frailty index and train an AI tool to apply that index during and after hospitalization. A secondary objective is to examine the relationship between nutritional status, thrombo-inflammatory markers, and the gender-oriented frailty score. The goal is to produce a practical, automated tool that incorporates sex and gender characteristics into frailty prediction for routine clinical use.
Why it matters
Potential benefit: If successful, the tool could help clinicians identify frail patients earlier and tailor care by accounting for sex and gender-related factors.
How similar studies have gone: Existing frailty indices and some AI prediction models have shown promise, but a gender-oriented frailty index combined with an AI tool remains relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients admitted in internal medicine or geriatric units * age \> 55 years Exclusion Criteria: * Surgical patients, critical illness requiring admission to an intensive care unit, presence of an active malignancy.
Where it's running
-
Sapienza University of Rome, University Hospital Policlinico Umberto I, Rome - UOC Internal medicine and Immunology
Roma, Italy Recruiting
Study contacts
- Study coordinator: Stefania Basili
- Email: stefania.basili@uniroma1.it
- Phone: +393393452523
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
FAXAGE: Fasting and exercise to slow aging in older adults.
This project will test whether time-restricted eating, exercise, or both can slow biological aging in people 65 and older.
-
Differentiating heart disease in autoimmune vs. type 2 diabetes
This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.
-
Probiotic Bifidobacterium bifidum for formula-fed infants with colic (with or without eczema)
This study tests whether daily Bifidobacterium bifidum drops can reduce crying time in formula-fed infants 5 months or younger with colic, and whether it helps those with or without atopic dermatitis.
-
Normast 3 for adults with diabetic polyneuropathy
A 12-week trial will test whether Normast 3 helps reduce nerve pain in adults with diabetic polyneuropathy compared with a placebo.
-
Early Wound Healing and Outcomes of Regenerative Periodontal Surgery
This study looks to see if healing in the first 1–2 weeks after periodontal regenerative surgery can predict how well the treatment works at 12 months in people with advanced periodontitis.
-
Transcutaneous Vagus Nerve Stimulation for Fibromyalgia Pain and Autonomic Dysfunction
This study tests a non-invasive nerve stimulation method to see if it helps people with fibromyalgia who have widespread pain and autonomic symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.